HHRG Berhad, an investment holding company, (0175) Fair Value & Analysis
Consumer Defensive · MY · Market cap 86.0M MYR
Fair value as of: Jun 26, 2026
From 12 valuation models · updated 3 days ago
Fair value updated Jun 26, 2026 — revised from 0.1400 MYR to 0.1350 MYR (−3.6%) since Jun 24, 2026. Share price −10.5% over the past month.
Price vs Fair Value (12 months)
12‑month range 0.0529 MYR – 0.1535 MYR · fair‑value band 0.1170 MYR – 0.1710 MYR · the 0.0900 MYR price screens below the 0.1350 MYR fair value. As of Jun 26, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
HHRG Berhad, an investment holding company, (0175) currently trades at 0.0900 MYR, while our model-based Fair Value estimate is 0.1350 MYR — implying the stock looks roughly 50.0% undervalued today. We read business quality at 84/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
Over the trailing twelve months, HHRG Berhad, an investment holding company, generated revenue of 106M MYR at a net margin of -0.8%. Revenue declined 26.8% year over year. It earns a return on equity of 4.0%. Net debt stands at 14.0M MYR. Fundamentals as of Jun 26, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.
About the company
HHRG Berhad, an investment holding company, engages in the manufacture and trading of coconut biomass materials and value-added products in Malaysia, the United Kingdom, Japan, China, and internationally. It operates through Biomass Material and Value-added Products; Furniture Products; Money Lending Services; and Investment Holding and Others segments. The company manufactures and trades coconut fiber and related products, bio-oil and oil palm, empty fruit bunches fiber, and related products; bio-compost and agrochemical products; and furniture products. It also engages in manufacturing and marketing of mattress and related products; and operates power plant and boiler turbine system for electricity generation and steam production. In addition, the company owns, develops, leases, trades, and manages real estate properties. Additionally, it involved in the money lending activities; Processing of coconut fibre, fibre sheet, and peat; trading, export, and import of general goods; and …
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
HHRG Berhad, an investment holding company, reported revenue of 182M MYR in FY2025 versus 104M MYR in FY2021, a compound +15.2%/yr. Reported net income was 10.4M MYR in FY2025, compounding −8.4%/yr from FY2021.
Open the full interactive analysis →
Similar stocks
6 more Farm Products stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Archer-Daniels-Midland Company ADM | $81.28 | $38.31 | -53% |
| MHP SE MHPC | $0.0854 | $0.0100 | -88% |
| Muyuan Foods Group 002714 | ¥33.95 | ¥119.07 | +251% |
| Bunge Global SA BG | $129.13 | $136.85 | +6% |
| Tyson Foods, Inc TSN | $58.73 | $34.80 | -41% |
| Wens Foodstuff Group 300498 | ¥12.89 | ¥6.35 | -51% |
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is HHRG Berhad, an investment holding company, (0175) undervalued?
What is the fair value of 0175?
What is the quality score of 0175?
What is the revenue of HHRG Berhad, an investment holding company, (0175)?
What is the net profit margin of 0175?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.